Pluri is pushing the boundaries of science and engineering to create cell-based products for commercial use and is pioneering a biotech revolution that promotes global wellbeing and sustainability. The Company’s technology platform, a patented and validated state-of-the-art 3D cell expansion system, advances novel cell-based solutions for a range of initiatives— from medicine and climate change to food scarcity, animal cruelty and beyond. Pluri’s method is uniquely accurate, scalable, cost-effective, and consistent from batch to batch. Pluri currently operates in the field of regenerative medicine and food-tech and aims to establish partnerships that leverage the company’s 3D cell-based technology to additional industries that require effective, mass cell production. To learn more, visit us at www.pluri-biotech.com or follow us on LinkedIn and Twitter.

Biotechnology

Food & Beverage

Health Services

Pluri

Yaky Yanay

Oren Kochavi

Lior Raviv

Nimrod Bar Zvi

Andy Lewin

Chen Franco

Orly Amiran

John Dvor

Arthur MacHlenkin

Efrat Kaduri

Leadership Team

Engineering and Quality Assurance Team

Business and Strategy

Scientific and Technical Team

Teams at Pluri

Leadership Team

Engineering and Quality Assurance Team

Business and Strategy

Scientific and Technical Team